GELS
What one share of Gelteq Limited holds
Pharmaceutical Preparations
Gelteq Limited’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-06-30; the balance sheet is as of 2025-06-30.
| Sales | $0.01 |
|---|---|
| Profit | −$0.46 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.39 |
| Cash and investments | $0.02 |
| Debt | $0.30 |
| Book value | $1.12 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | $0.01 | −$0.30 | $0.00 | −$0.15 | — | $1.57 |
| 2024 | — | −$0.29 | $0.00 | −$0.09 | — | $1.24 |
| 2025 | $0.01 | −$0.46 | $0.00 | −$0.39 | — | $1.12 |